Gazerani Parisa
International journal of molecular sciences, 2019
Abstract
Parkinson's disease (PD) is a complex neurological disorder classically characterized by impairments in motor system function associated with loss of dopaminergic neurons in the substantia nigra. After almost 200 years since the first description of PD by James Parkinson, unraveling the complexity of PD continues to evolve. It is now recognized that an interplay between genetic and environmental factors influences a diverse range of cellular processes, reflecting on other clinical features including non-motor symptoms. This has consequently highlighted the extensive value of early clinical diagnosis to reduce difficulties of later stage management of PD. Advancement in understanding of PD has made remarkable progress in introducing new tools and strategies such as stem cell therapy and deep brain stimulation. A link between alterations in gut microbiota and PD has also opened a new line. Evidence exists of a bidirectional pathway between the gastrointestinal tract and the central nervous system. Probiotics, prebiotics and synbiotics are being examined that might influence gut-brain axis by altering gut microbiota composition, enteric nervous system, and CNS. This review provides status on use of probiotics for PD. Limitations and future directions will also be addressed to promote further research considering use of probiotics for PD.
Keywords
Parkinson’s disease; dysbiosis; gastrointestinal; gut; microbiota; prebiotics; probiotics; synbiotics.
Conflict of interest statement
The “Probiotic Research Initiative™” is a collaboration between Bifodan A/S (Hundested, Denmark) and the Biomedicine group at Aalborg University. The author is affiliated with the Biomedicine group at Aalborg University and, in collaboration with Bifodan A/S, has performed research related to applying the probiotic Lactobacillus rhamnosus PB01 (DSM 14870) produced by Bifodan A/S in several domains including pain, obesity, and fertility.PMID: | 31450864 |
---|---|
DOI: | 10.3390/ijms20174121 |
PMCID (Free PMC Article): | PMC6747430 |
Category: | General properties of Probiotics |
Articles similar to "Probiotics for Parkinson's Disease."
- The properties of Probiotics: Probiotics, Prebiotics, and Synbiotics. (According to the German definition, probiotics are defined viable microorganisms, sufficient amounts of which reach the intestine in an active state and thus exert positive health effects...)
- The properties of Probiotics: Effects of Lactobacillus Acidophilus LA-3 on Physicochemical and Sensory Parameters of Açaí and Mango Based Smoothies and Its Survival Following Simulated Gastrointestinal Conditions. (The effects of the incorporation of Lactobacillus acidophilus LA3 (inoculated at 9 log CFU/mL) on physicochemical parameters, contents of sugars and organic acids, phenolic profile and sensory aspects of açaí (AS) and mango based smoothies (MS) during 28 days of refrigerate storage were assessed...)
Previous article
Probiotics, Prebiotics, and Synbiotics.